Navigation Links
Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
Date:9/2/2009

s that meet EU criterion after a single shot. No severe adverse effects were reported after inoculation. Based on the results of the evaluation, the experts unanimously agreed that Sinovac's H1N1 vaccine is suitable for all people from three to 60 years old and the vaccination schedule is a single shot. The result of the experts' evaluation conference will be submitted to SFDA on September 1st, which will be the primary basis for the SFDA to issue the production license.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A n
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. Sinovac Reports Unaudited First Quarter 2009 Financial Results
5. Sinovac Schedules 2008 Annual General Meeting
6. Sinovac Reports Unaudited Second Quarter 2009 Financial Results
7. Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
8. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 The age spots, wrinkles ... over the age of 30 are now explored in a ... the best eye creams for women over 30 are introduced ... http://cherrynews.com/best-nourishing-eye-serum . , The use of creams as an ... partly based on cost, according to the information in the ...
(Date:7/23/2014)... Edmond, Oklahoma (PRWEB) July 23, 2014 ... North America’s leading provider of in-home care for ... Healthy Longevity Webinar Series featuring experts in a ... upcoming webinar will feature licensed clinical social worker ... the most common causes of caregiver stress and ...
(Date:7/23/2014)... NY, July 24, 2014) If past experience is ... State are about to get a lot more recognition ... already on the books allowing NPs to provide primary ... patient care and better relationships with physicians and administrators, ... study from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... Celebrating a decade of philanthropy in 2014, ... awarding of $1,070,000 in grants to 20 New Jersey ... the Foundation’s 1,000th grant. , “The Horizon Foundation for ... supporting community-based organizations that are working to improve public ... Garden State,” said Robert A. Marino, Horizon Blue Cross ...
(Date:7/23/2014)... growing body of research suggesting a safe and ... postmenopausal breast cancer, with fewer detrimental side effects ... therapies. The study will be published in final ... Biology and Endocrinology . , Breast cancer is ... the United States. Approximately 70% of breast cancers ...
Breaking Medicine News(10 mins):Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:New York law offers nurses more recognition, responsibility 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... MINNEAPOLIS, Oct. 17 Health Fitness Corp.,(OTC Bulletin Board: ... results for the third quarter ended September 30,2007, on ... Company also,announced that it will hold a conference call ... call will be Dr. Gregg Lehman, President and,Chief Executive ...
... Fla., Oct. 17 "As a physician,you hear all ... says Dr. Terry,D. Hashey, Medical Director of First Coast ... Corral Flu Campaign.,The most common that Dr. Hashey reports ... the flu shot. "That couldn,t be farther from the ...
... outcomes at Houston Northwest Medical ... nation,s best for several service lines, HOUSTON, ... Hospital Quality in America Study issued today, Houston,Northwest ... service,lines including overall gastrointestinal services, gastrointestinal,surgery, stroke, general ...
... that hospital-caused MRSA infections are about triple, previous estimates. The Centers ... and have failed to call on hospitals to take the ... ... infections., NEW YORK, Oct. 17 Today, data in an article,published ...
... WEST CHESTER, Ohio, Oct. 16 AtriCure, Inc.,(Nasdaq: ... leader in cardiac surgical,ablation products, today announced that ... which physicians have adopted to,treat atrial fibrillation (AF), ... Dr. James H. McClelland, an,electrophysiologist, and colleagues from ...
... breast cancer drugs called taxanes, which include Taxol (paclitaxel) ... part of chemotherapy following surgery for cancers that have ... research. , The review, which compared chemotherapy regimes ... studies including 21,191 women. , For patients, this study ...
Cached Medicine News:Health News:Health Fitness Corp. to Report Third Quarter 2007 Financial Results on November 5, 2007 2Health News:Flu Myths Abound in Flu Season 2Health News:Houston Northwest Medical Center's Patient Outcomes Superior 2Health News:Houston Northwest Medical Center's Patient Outcomes Superior 3Health News:The Journal of the American Medical Association (JAMA) Article Reveals Scope of MRSA Infections 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 2Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 3
(Date:7/23/2014)... 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: ... on its expertise in opioid antagonists, announced today ... application ("IND") with respect to its naloxone-based opioid ... that it has received an additional commitment from ... of the National Institutes of Health ("NIH"), to ...
(Date:7/23/2014)... , July 23, 2014  Silk Road Medical, ... transcarotid treatment of intra- and extra-cranial cerebrovascular disease, ... Wallace to the position of Chief Technology ... the company,s Research and Development efforts across its ... Prior to joining Silk Road Medical, ...
(Date:7/23/2014)... 2014  ACON Equity Partners III, L.P., a private ... announced it has completed the purchase of Injured Workers ... and Parthenon Capital Partners. IWP is a leading specialty ... Automobile Personal Injury Protection and Personal Injury pharmacy markets ... As part of this transaction, ACON partnered ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3
... Jan. 16, 2012 Boston Scientific Corporation (NYSE: ... its ORION trial, demonstrating excellent outcomes for the Company,s ... artery disease, a form of peripheral artery disease associated ... Results were presented today by Daniel Clair, M.D., FACS, ...
... SAN FRANCISCO, Jan. 16, 2012 Dicom Systems ( ... is pleased to announce their selection as the Vendor ... California-based full service physician-owned teleradiology group. ... you have the capacity to turn your current storage ...
Cached Medicine Technology:Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 2Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 4Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 5ONRAD, Inc. Chooses Dicom Systems' Vendor Neutral Archive 2
... to stain intraocular membranes in vitreoretinal surgery, ... injecting Membraneblue in an air-filled vitreous cavity, ... the dye. After removal of all excess ... can easily be distinguished from the underlying, ...
Blanket protection against heavier bleeding....
Auto refractometer....
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
Medicine Products: